James H. Reamer

Array ( [id] => 3889738 [patent_doc_number] => 05777171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Method of purifying arylphenones' [patent_app_type] => 1 [patent_app_number] => 8/953558 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2847 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/777/05777171.pdf [firstpage_image] =>[orig_patent_app_number] => 953558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478092 [patent_doc_number] => 06344480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Oral analgesic compositions' [patent_app_type] => B1 [patent_app_number] => 08/953146 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2063 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344480.pdf [firstpage_image] =>[orig_patent_app_number] => 08953146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048592 [patent_doc_number] => 05968918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Method for the prevention of coronary artery spasm' [patent_app_type] => 1 [patent_app_number] => 8/953340 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2730 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968918.pdf [firstpage_image] =>[orig_patent_app_number] => 953340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989523 [patent_doc_number] => 05919490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Preparation for improving the blood supply containing hard magnetic particles' [patent_app_type] => 1 [patent_app_number] => 8/951701 [patent_app_country] => US [patent_app_date] => 1997-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5390 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919490.pdf [firstpage_image] =>[orig_patent_app_number] => 951701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048605 [patent_doc_number] => 05968919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Hormone replacement therapy drug formulations for topical application to the skin' [patent_app_type] => 1 [patent_app_number] => 8/953014 [patent_app_country] => US [patent_app_date] => 1997-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5989 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968919.pdf [firstpage_image] =>[orig_patent_app_number] => 953014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3791369 [patent_doc_number] => 05840958 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => '1S to 1R Epimerizations of pyrethroid intermediates' [patent_app_type] => 1 [patent_app_number] => 8/950819 [patent_app_country] => US [patent_app_date] => 1997-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1864 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840958.pdf [firstpage_image] =>[orig_patent_app_number] => 950819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937852 [patent_doc_number] => 05972946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Acetamide derivative, process for preparing the same, and a pharmaceutical composition containing the same' [patent_app_type] => 1 [patent_app_number] => 8/930604 [patent_app_country] => US [patent_app_date] => 1997-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22681 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972946.pdf [firstpage_image] =>[orig_patent_app_number] => 930604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4003772 [patent_doc_number] => 05859046 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Biologically active oreido derivatives useful in the treatment of multiple sclerosis' [patent_app_type] => 1 [patent_app_number] => 8/930598 [patent_app_country] => US [patent_app_date] => 1997-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6022 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859046.pdf [firstpage_image] =>[orig_patent_app_number] => 930598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4065329 [patent_doc_number] => 05895787 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-20 [patent_title] => 'Treatment of fibromyalgia and related disorders' [patent_app_type] => 1 [patent_app_number] => 8/954995 [patent_app_country] => US [patent_app_date] => 1997-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2619 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/895/05895787.pdf [firstpage_image] =>[orig_patent_app_number] => 954995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034860 [patent_doc_number] => 05942539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Methods of treating or preventing endometriosis with phytoestrogens' [patent_app_type] => 1 [patent_app_number] => 8/943559 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7003 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942539.pdf [firstpage_image] =>[orig_patent_app_number] => 943559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3926456 [patent_doc_number] => 05952352 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Heterocyclic compounds' [patent_app_type] => 1 [patent_app_number] => 8/942018 [patent_app_country] => US [patent_app_date] => 1997-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3413 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 317 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952352.pdf [firstpage_image] =>[orig_patent_app_number] => 942018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4007622 [patent_doc_number] => 06005147 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Method of producing 3, 5, 5-trimethylcyclohexa-3-ene-1-one(.beta.-isophorone) by the isomerization of 3, 5, 5-trimethylcyclohexa-2-ene-1-(.alpha.-isophorone)' [patent_app_type] => 1 [patent_app_number] => 8/938822 [patent_app_country] => US [patent_app_date] => 1997-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5566 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/005/06005147.pdf [firstpage_image] =>[orig_patent_app_number] => 938822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995559 [patent_doc_number] => 05985843 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Pharmaceutical composition containing sucralfate' [patent_app_type] => 1 [patent_app_number] => 8/930263 [patent_app_country] => US [patent_app_date] => 1997-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 2983 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985843.pdf [firstpage_image] =>[orig_patent_app_number] => 930263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407750 [patent_doc_number] => 06172069 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Method for preventing or reducing photosensitivity and or photoxicity reaction to medications' [patent_app_type] => 1 [patent_app_number] => 8/936572 [patent_app_country] => US [patent_app_date] => 1997-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25533 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172069.pdf [firstpage_image] =>[orig_patent_app_number] => 936572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833027 [patent_doc_number] => 05814598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Use of unsaturated aliphatic esters in perfumery' [patent_app_type] => 1 [patent_app_number] => 8/936196 [patent_app_country] => US [patent_app_date] => 1997-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1913 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814598.pdf [firstpage_image] =>[orig_patent_app_number] => 936196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217436 [patent_doc_number] => 06110975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Treatment of neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 8/933145 [patent_app_country] => US [patent_app_date] => 1997-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3567 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110975.pdf [firstpage_image] =>[orig_patent_app_number] => 933145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3944937 [patent_doc_number] => 05990177 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway' [patent_app_type] => 1 [patent_app_number] => 8/933144 [patent_app_country] => US [patent_app_date] => 1997-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3386 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 304 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990177.pdf [firstpage_image] =>[orig_patent_app_number] => 933144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217436 [patent_doc_number] => 06110975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Treatment of neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 8/933145 [patent_app_country] => US [patent_app_date] => 1997-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3567 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110975.pdf [firstpage_image] =>[orig_patent_app_number] => 933145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217436 [patent_doc_number] => 06110975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Treatment of neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 8/933145 [patent_app_country] => US [patent_app_date] => 1997-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3567 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 281 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110975.pdf [firstpage_image] =>[orig_patent_app_number] => 933145 [rel_patent_id] =>[rel_patent_doc_number] =>)